LOG IN
Analysis
Featured Analysis
Articles by Category
Current Editions
Data Graphics
Discovery & Translation
Hot Topics
BioCentury Podcasts
Special Reports & Presentations
White Papers
BCIQ Data
BCIQ
Company Profiles
Product Profiles
Target Profiles
Financial Dashboards
Events
All Events
East-West Healthcare Reception
Bio€quity Europe
Grand Rounds — U.S.
Grand Rounds — Europe
China Healthcare Summit
East-West Biopharma Summit 2026
Bio€quity Europe 2026
Podcast: The BioCentury Show
Podcast: BioCentury This Week
Webinars
My Workspace
About BioCentury
Management
Analysts & Research Team
Scientific Advisory Board
Contact
Contact Us
Forgot Password
Request a Subscription
Sponsorship & Branding Inquiry
Media Kit
Request BioCentury's BCIQ Brochure
Customer Resource Center
Career Opportunities
Request a Trial
Company Profiles
Target Profiles
Product Profiles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Company Profiles
Target Profiles
Product Profiles
China Healthcare Summit
Bio€quity Europe
Explore BCIQ profiles by entering a company name.
REQUEST A FREE TRIAL
Overview
Pipeline
Deals
Financings
Articles
Novadip Biosciences S.A.
Headquarters:
Mont-Saint-Guibert, Belgium
Website:
http://www.novadip.com
Year Founded:
2013
Status:
Private
BioCentury
|
May 1, 2025
Management Tracks
Augustine follows up venture round with pair of C-suite hires
Plus: Management changes at Cidara, Fujifilm Cellular Dynamics and Transneural
Read More
BioCentury
|
Apr 2, 2025
Management Tracks
FDA names Scott Steele acting head of CBER after Marks’ ouster
Plus: New managing directors at Vida and updates from Nxera, Korro and Novadip
Read More
BioCentury
|
Sep 13, 2024
Data Byte
PanTera largest Belgian A round to date
Only nine other biotechs have raised over $25 million since 2015
Read More
BioCentury
|
Jan 4, 2023
Management Tracks
Ex-Checkmate CEO Bash to lead ZielBio
Plus: Allogene’s Amado joins Zai Lab, and updates from bluebird bio, Rejuvenate, Novadip and more
Read More
BioCentury
|
Nov 4, 2022
Deals
Nov. 4 Quick Takes: Bayer returns rights to Ionis’ antithrombotic
Plus Vicore gains on IPF data and updates from Acrivon, BioAtla, Novadip and more
Read More
BioCentury
|
Oct 29, 2021
Product Development
Oct. 28 Quick Takes: Rafael shares sink on oncology readouts
Phathom, HealthCare Royalty pull offerings, plus Merck, Sanofi raise guidance after strong quarters and more
Read More
BioCentury
|
Dec 13, 2018
Company News
Management tracks: Tamura reclaims CEO role at Sosei
Read More
BioCentury
|
Apr 7, 2017
Finance
Fast-growing evergreen
How returns from Ogeda’s exit could affect Fund+’s investment strategy
Read More
BioCentury
|
Oct 26, 2016
Financial News
Fund+ closes EUR 125M fund
Read More
BioCentury
|
Sep 14, 2015
Financial News
Novadip completes venture financing
Read More
Items per page:
10
1 - 10 of 11
Help Center
Username
Request Training
Submit Data Correction
Ask a Question
Elevio by Dixa
Help